Drug search by name

Gonal-f RFF Rediject and Tumors

Result of checking the interaction of drug Gonal-f RFF Rediject and disease Tumors for safety when used together.

Check result:

Gonal-f RFF Rediject <> Tumors

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of follicle stimulating hormone is contraindicated in patients with sex hormone-dependent tumors of the reproductive tract and accessory organs (ovary, breast, uterus) and in patients with pituitary tumors. FSH is required for normal sex hormone production, which may be detrimental in these patients. Patients in later reproductive life have a greater predisposition to endometrial carcinoma.

References:

"Product Information. Gonal-F (follicle stimulating hormone)." Serono Laboratories Inc, Norwell, MA.
"Product Information. Follistim (follicle stimulating hormone)." Organon, West Orange, NJ.

Gonal-f RFF Rediject

Generic Name: follicle stimulating hormone

Brand Name: Gonal-F, Gonal-f RFF, Gonal-f RFF Rediject, Follistim AQ Cartridge, Gonal-F, Follistim, Follistim AQ, Puregon, Gonal-f RFF Pen, Gonal-F Pen, Gonal-F, PUREGON

Synonyms: n.a.

What is Gonal-f RFF Rediject?